{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:23:37Z","timestamp":1790004217124,"version":"4.0.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.09.036","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T14:08:56Z","timestamp":1258553336000},"page":"7162-7166","source":"Crossref","is-referenced-by-count":29,"title":["Rabies post-exposure prophylaxis with purified equine rabies immunoglobulin: One-year follow-up of patients with laboratory-confirmed category III rabies exposure in the Philippines"],"prefix":"10.1016","volume":"27","author":[{"given":"Beatriz P.","family":"Quiambao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel Z.","family":"Dy-Tioco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby M.","family":"Dizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn E.","family":"Crisostomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk E.","family":"Teuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.09.036_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(02)00287-6","article-title":"Rabies re-examined","volume":"2","author":"Rupprecht","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.036_bib2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s11910-006-0047-2","article-title":"Rabies","volume":"6","author":"Hemachudha","year":"2006","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.vaccine.2009.09.036_bib3","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.trstmh.2008.04.008","article-title":"Viewpoint: management of human rabies","volume":"102","author":"Wilde","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.09.036_bib4","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2009.09.036_bib5","unstructured":"Alliance for Rabies Control. Rabies facts. http:\/\/www.rabiescontrol.net\/EN\/About-Rabies\/Rabies-Facts.html; 2009 [accessed 05.06.09]."},{"key":"10.1016\/j.vaccine.2009.09.036_bib6","unstructured":"Rabies vaccines. WHO position paper. WER 2008;82:425\u201336."},{"key":"10.1016\/j.vaccine.2009.09.036_bib7","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMcp042140","article-title":"Clinical practice prophylaxis against rabies","volume":"351","author":"Rupprecht","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.09.036_bib8","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1371\/journal.pntd.0000243","article-title":"Rabies post-exposure prophylaxis in the Philippines: health status of patients having received purified equine F(ab\u2032)(2) fragment rabies immunoglobulin (Favirab)","volume":"2","author":"Quiambao","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2009.09.036_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0001-706X(98)00038-2","article-title":"Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine","volume":"70","author":"Lang","year":"1998","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2009.09.036_bib10","first-page":"69","article-title":"Comparative evaluation of the rabies fluorescent antibody test and direct microscopic examination at the Research Institute for Tropical Medicine","volume":"21","author":"Robles","year":"1992","journal-title":"Phil J Microbiol Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T05:23:34Z","timestamp":1544851414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09013607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":10,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X09013607"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}